S1PR1 and breast cancer: These findings suggest that the S1P1/AKT and S1P1/ERK-1/2 modules might represent spatially restricted signaling pathways in ER+ breast cancer patients that confer poor clinical prognosis by protecting cancer cells from apoptosis and/or promoting their growth/invasion.